Zasocitinib (Dose A) — catalyst calendar

1 verified catalyst event(s) referencing Zasocitinib (Dose A), each linked to its official source. Verified as of 2026-11-05.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-05
in 3mo
ESTIMATED
READOUT
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Hidradenitis Suppurativa
TAK TAKEDA PHARMACEUTICAL CO LTD Zasocitinib (Dose A) ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.